Osteonecrosis amid the COVID-19 pandemic
Rheumatology International · 2023
DOI: 10.1007/s00296-023-05332-3 ↗Kurz gefasst
Leserbrief in der Zeitschrift Rheumatology International, 2023. Verfasst von Chokan Baimukhamedov und 4 weiteren Autor:innen. Beteiligte Einrichtung: South Kazakhstan Medical Academy, Shymkent, Kazakhstan. chokanbay@gmail.com. Hauptthemen laut MEDLINE: COVID-19, Osteonecrosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The COVID-19 pandemic has changed our understanding of numerous autoimmune diseases, clinical conditions, and complications triggered by the novel coronavirus and related treatments. Numerous new clinical issues have emerged as a result. The latest evidence on osteonecrosis (ONC), or avascular necrosis, after combined COVID-19 treatment at the beginning of the pandemic, is one of the proofs of the emerging issues [1]. The global medical community is alerted on the risk of corticosteroid therapy of COVID-19 in corticosteroid-naïve subjects that may complicate with hip and knee pain and ONC at 1-year follow-up [1]. The follow-up study highlights the importance of MRI for evaluating the origin of hip and knee pain and timely detecting ONC after the combined treatment with corticosteroids. The authors diagnosed ONC at 2-year follow-up of 8 corticosteroid-naïve subjects exposed to variable doses and durations of corticosteroid therapy [1]. One of the eye-catching features of the study is the wide range of cumulative corticosteroid doses – 50–20,675 mg prednisolone, although it is unclear why the extremely high dose of 20,675 mg was used and whether it resulted in ONC. The cumulative dose of 400 mg prednisolone, or 6 mg/daily dexamethasone for 10 days, seems the highest acceptable extreme in severe COVID-19 in view of the RECOVERY trial outcomes [2].
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- South Kazakhstan Medical Academy, Shymkent, Kazakhstan. chokanbay@gmail.com.
- Shymkent Medical Centre of Joint Diseases, Shymkent, Kazakhstan. chokanbay@gmail.com.
- South Kazakhstan Medical Academy, Shymkent, Kazakhstan.
- Shymkent Medical Centre of Joint Diseases, Shymkent, Kazakhstan.
ORCID-Profile: Chokan Baimukhamedov, Aliya Botabekova, Zhanyl Lessova, Bekzhat Abshenov, Nursezim Kurmanali
Zitieren
APA
Baimukhamedov, C., Botabekova, A., Lessova, Z., Abshenov, B., & Kurmanali, N. (2023). Osteonecrosis amid the COVID-19 pandemic. Rheumatology International. https://doi.org/10.1007/s00296-023-05332-3
Vancouver
Baimukhamedov C, Botabekova A, Lessova Z, Abshenov B, Kurmanali N. Osteonecrosis amid the COVID-19 pandemic. Rheumatology International. 2023. doi:10.1007/s00296-023-05332-3
BibTeX
@article{Baimukhamedov2023,
author = {Baimukhamedov, Chokan and Botabekova, Aliya and Lessova, Zhanyl and Abshenov, Bekzhat and Kurmanali, Nursezim},
title = {Osteonecrosis amid the COVID-19 pandemic},
journal = {Rheumatology International},
year = {2023},
doi = {10.1007/s00296-023-05332-3}
}
EUVIMED